Aclidinium bromide oral inhalation powder approved for COPD.
Kate
K
Traynor
D000280:Administration, Inhalation; D000284:Administration, Oral; D018680:Cholinergic Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D017277:Drug Approval; D006801:Humans; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*; D014326:Tropanes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D018680:Cholinergic Antagonists; D014326:Tropanes; C542859:aclidinium bromide